Evidence map›Paper›PMID 34080400›Full record

ArticleJournal of biomedical optics2021

High optode-density wearable diffuse optical probe for monitoring paced breathing hemodynamics in breast tissue.

Samuel Spink, Fei Teng, Vivian Pera, Hannah Peterson, Tim Cormier, Alexis Sauer-Budge, David Chargin, Sam Brookfield, Adam Eggebrecht, Naomi Yu Ko and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of biomedical optics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Samuel SpinkBoston Univ., United States.
Fei TengBoston Univ., United States.
Vivian PeraBoston Univ., United States.
Hannah PetersonBoston Univ., United States.
Tim CormierBoston Univ., United States.
Alexis Sauer-BudgeBoston Univ., United States.
David CharginBoston Univ., United States.
Sam BrookfieldBoston Univ., United States.
Adam EggebrechtWashington Univ. School of Medicine in St. Louis, United States.
Naomi Yu KoBoston Medical Ctr., United States.
Darren RoblyerBoston Univ., United States.
Fraunhofer USA Center for Manufacturing Innovation · USBoston University · USBoston Medical Center · USWashington University in St. Louis · US

Funding

Center for Innovation in Point of Care Technologies for the Future of Cancer CareU54EB015403 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI KLAPPERICH, CATHERINE M. · 2012 to 2016
$8.9M
NIBIB NIH HHS U54 EB015403
6 · The paper itself

Abstract

significanceDiffuse optical imaging (DOI) provides in vivo quantification of tissue chromophores such as oxy- and deoxyhemoglobin (HbO2 and HHb, respectively). These parameters have been shown to be useful for predicting neoadjuvant treatment response in breast cancer patients. However, most DOI devices designed for the breast are nonportable, making frequent longitudinal monitoring during treatment a challenge. Furthermore, hemodynamics related to the respiratory cycle are currently unexplored in the breast and may have prognostic value.

aimTo design, fabricate, and validate a high optode-density wearable continuous wave diffuse optical probe for the monitoring of breathing hemodynamics in breast tissue. APPROACH: The probe has a rigid-flex design with 16 dual-wavelength sources and 16 detectors. Performance was characterized on tissue-simulating phantoms, and validation was performed through flow phantom and cuff occlusion measurements. The breasts of N  =  4 healthy volunteers were measured while performing a breathing protocol.

resultsThe probe has 512 unique source-detector (S-D) pairs that span S-D separations of 10 to 54 mm. It exhibited good performance characteristics: μa drift of 0.34%/h, μa precision of 0.063%, and mean SNR  ≥  24  dB up to 41 mm S-D separation. Absorption contrast was detected in flow phantoms at depths exceeding 28 mm. A cuff occlusion measurement confirmed the ability of the probe to track expected hemodynamics in vivo. Breast measurements on healthy volunteers during paced breathing revealed median signal-to-motion artifact ratios ranging from 8.1 to 8.7 dB. Median ΔHbO2 and ΔHHb amplitudes ranged from 0.39 to 0.67  μM and 0.08 to 0.12  μM, respectively. Median oxygen saturations at the respiratory rate ranged from 82% to 87%.

conclusionsA wearable diffuse optical probe has been designed and fabricated for the measurement of breast tissue hemodynamics. This device is capable of quantifying breathing-related hemodynamics in healthy breast tissue.

Indexed as

BreastWearable Electronic DevicesDiagnostic ImagingHemodynamicsHumansOxyhemoglobinsPhantoms, ImagingOxyhemoglobinsbreast cancerdiffuse optical imagingdiffuse opticshemodynamicspaced breathingwearable

Identifiers

PMID34080400
PMCPMC8170390
OpenAlexW3165676717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.